New blood test detects 90% of aggressive prostate cancer cases, beating current screenings
A new blood test called Stockholm3 is outperforming traditional PSA screenings by detecting 90% of aggressive prostate cancer cases.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
A new blood test, Stockholm3, has demonstrated the ability to detect 90% of aggressive prostate cancer cases. This performance exceeds that of current screenings, specifically the PSA test, in identifying significant cancers.
Coverage from Fox News, Conexiant, and Oncodaily emphasizes the test's superior detection rates compared to PSA. Meanwhile, BioSpectrum Asia reports that researchers from India and New Zealand are exploring DNA-based approaches to further improve detection.
Future developments involve assessing whether Stockholm3 can consistently outperform PSA for screening purposes, as noted in Oncodaily coverage.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 2h ago.
Quick answers
What is the name of the new blood test?
The test is called Stockholm3.
How does it compare to current screenings?
According to coverage, it detects 90% of aggressive prostate cancer cases and has detected more significant cancers than the PSA test.
Who is researching further improvements in detection?
Researchers from India and New Zealand are exploring a DNA-based approach.
Coverage (4)
- Indo-NZ researchers explore DNA-based approach to improve prostate cancer detection BioSpectrum Asia · 6h ago
- Adam B. Weiner: Can Stockholm3 Outperform PSA for Prostate Cancer Screening? Oncodaily · 6h ago
- Stockholm3 Detected More Significant Prostate Cancers Than PSA Conexiant · 6h ago
- New blood test detects 90% of aggressive prostate cancer cases, beating current screenings Fox News · 6h ago
Topics
Related trends
Prostate cancer blood test detects twice as many cases
A new multicomponent blood test is demonstrating higher detection rates for clinically significant prostate cancer compared to traditional PSA testing.
Thousands of men with prostate cancer will now be offered high-powered radiotherapy on the NHS
The NHS is expanding access to high-powered radiotherapy for thousands of men with prostate cancer to reduce treatment times.
Jeremy Clarkson issues stark cancer warning to public: ‘Please go and get checked’
Jeremy Clarkson is urging the public to seek medical screenings after revealing his battle with aggressive prostate cancer.